The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
20
No.
18
May 06, 1994
- NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding
- In Brief: Senate Cancer Coalition Hearing On Tamoxifin Planned for May 11; Bresnick Leads AACR
- Fisher and Redmond Subject Of Misconduct Investigation; ORI
- Herberman Outlines NSABP restructuring In Plan To NCI
- DCT Advisors Approve Increased Spending On Trials Monitoring
- Possible Breach of Patient Confidentially By Calif. Physician; NCI
TCL
Vol.
20
No.
19
May 13, 1994
- NCI Considers Making Prevention Trial From NSABP; Other Groups Approached
- In Brief: Connell Is President of Komen Foundation; Ravikumar Moves to New Jersey Cancer Inst.
- NCI Advisors: Resume Prevention Trial, Add Edometrial Sampling
- Fisher, Redmond Removed Fro Official posts At NSABP
- Pittsburgh Reprimands Staff For Use of Univ. Resources In Mailing
- R. Lee Clark, 87, M.D. Anderson Mastermind, dies
- Women Surgeons: We Need Answers On Tamoxifin Now
TCL
Vol.
20
No.
20
May 20, 1994
- News Organizations Protest invitation-Only Press Conferences, Exclusion of Reporters
- In Brief: Mayo Director Kovach Moves To City Of Hope; Seattle Institutions Win Gene Therapy
- Editorial: Ambiance Through Exclusion
- NIH Advisors Urge Stronger Peer Review, Clinical Center Renewal
- NCI To Recompete NSABP in 1995, Chabner tells Senate
- Letter To the Editor: Screening Revisited
TCL
Vol.
20
No.
21
May 27, 1994
- NSABP Accrual To Resume Soon; Group ponders Elections, Move To Fox Chase
- In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial
- Results of NSABP Studies Unchanged When Falsified Data is Excluded: Fisher
- ASCO TO NCI: Review Auditing Procedures, Re-Establish Trust
- Clinton Seeks Cut In NIH Increase
- Advisory Council To Be Named For Alternative Medicine Cuts
- James Shannon, 89, Led NIH In 1960’s Period of Growth
TCL
Vol.
20
No.
22
June 03, 1994
- New NCAB Task Force On Clinical Trials Is Attempt To Bring NCI, Groups Together
- In Brief: Ford Named Acting Deputy Director, DCPC; Foundation Leads Oncology Administrators
- NSABP Investigator Recounts Loyalty To Fisher, “Betrayal”
- NCAB Member Seeks Broder’s Resignation, Gets No support
- Pittsburgh Broadens Misconduct Inquiry
- Senate Appropriators Plan Hearing On NCI Ouster Of Fisher
- DCE director Adamson To Retire August 31
- DCPC Advisor O Trial Of Cervical Lesion Management With HPV
TCL
Vol.
20
No.
23
June 10, 1994
- NSABP Agrees To Three-Month Search for Chairman Candidates, Review Of Plans
- In Brief: Kalt Named Director, NCI extramural Div.; Browning Is Deputy; Other DEA Staff Changes
- 8 Pittsburg Employees Started Coalition That Lasted 8 Days
- NCI To Require Reports On Adverse Drug Reactions From Trials
- Cooperative Groups Woven Through Fabric Of NCI, Broder Says
- Cancer Center Planning Grants Recompetition Approved By Advisors
TCL
Vol.
20
No.
24
June 17, 1994
- NCI Agrees To give NSABP One Year Until Competition; Advisors OK Concept
- In Brief: William Blot, Michael Grever, Others To Leave NCI; RAC Approves Naked DNA Vaccine Trial
- DCT Board Restores Funding to Rosenberg’s Lymphocyte Projects
- Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume
- House Subcommittee allocates $11.3 Billion To NIH, $2.1 Bil. To NCI
- NCI Audit Finds “Low Quality” Research At Calif. Foundation
- DCE Board Approves Study of Breast Cancer On Long Island